Answers are grounded in this paper and cite their sources.
Retrospective OSF archive for a systematic review and exploratory meta-analysis comparing adjusted real-world treatment persistence/discontinuation estimates for IL-23p19 inhibitors versus IL-17 pathway inhibitors in adults with plaque psoriasis. This project contains the review protocol, search strategies, PRISMA flow diagram, screening and full-text eligibility materials, extraction workbook, ROBINS-I assessments, GRADE summary, R analysis code, and generated figures. The review was not prospectively registered; the OSF record was created before journal submission to support transparency and reproducibility.
No takes yet. Share an insight, caveat, or question.
Migdady et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: